Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism

Metformin inhibits cancer cell proliferation and epidemiology studies suggest an association with increased survival in cancer patients taking metformin, however, the mechanism by which metformin improves cancer outcomes remains controversial. To explore how metformin might directly affect cancer ce...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Fendt, Sarah-Maria, Bell, Eric L., Keibler, Mark A., Davidson, Shawn M., Wirth, Gregory J., Fiske, Brian, Mayers, Jared R., Schwab, Matthias, Bellinger, Gary, Csibi, Alfredo, Patnaik, Akash, Jose Blouin, Marie, Cantley, Lewis C., Guarente, Leonard, Blenis, John, Pollak, Michael N., Olumi, Aria F., Vander Heiden, Matthew G., Stephanopoulos, Gregory
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3930683/
https://ncbi.nlm.nih.gov/pubmed/23687346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-13-0080
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak